Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
RFL Stock Forecast 2025-2026
$1.45
Current Price
$53.99M
Market Cap
Buy 0
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to RFL Price Targets
N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A
RFL Price Momentum
+2.8%
1 Week Change
-13.7%
1 Month Change
-8.2%
1 Year Change
-11.0%
Year-to-Date Change
-41.2%
From 52W High of $2.47
+14.0%
From 52W Low of $1.27
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching Rafael Holdings (RFL) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on RFL and similar high-potential opportunities.
Latest RFL Stock Price Targets & Analyst Predictions
RFL has shown a year-to-date change of -11.0% and a 1-year change of -8.2%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for RFL. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
RFL Analyst Ratings
0
Buy
0
Hold
0
Sell
RFL Price Target Range
Low
N/A
Average
N/A
High
N/A
Current: $1.45
Latest RFL Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for RFL.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
Rafael Holdings Inc. (RFL) Competitors
The following stocks are similar to Rafael Holdings based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Rafael Holdings Inc. (RFL) Financial Data
Rafael Holdings Inc. has a market capitalization of $53.99M with a P/E ratio of 14.3x. The company generates $706,000 in trailing twelve-month revenue with a 75.8% profit margin.
Revenue growth is +13.2% quarter-over-quarter, while maintaining an operating margin of -4,661.0% and return on equity of -93.5%.
Valuation Metrics
Market Cap
$53.99M
Enterprise Value
$-6,624,480
P/E Ratio
14.3x
PEG Ratio
0.0x
Price/Sales
76.5x
Growth & Margins
Revenue Growth (YoY)
+13.2%
Gross Margin
+50.6%
Operating Margin
-4,661.0%
Net Margin
+75.8%
EPS Growth
+13.2%
Financial Health
Cash/Price Ratio
+133.8%
Current Ratio
9.3x
Debt/Equity
3.3x
ROE
-93.5%
ROA
-47.8%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Rafael Holdings Inc. (RFL) Business Model
About Rafael Holdings Inc.
What They Do
Invests in healthcare and real estate ventures.
Business Model
Rafael Holdings operates as a holding company, generating revenue through investments in biopharmaceutical companies and managing a portfolio of commercial real estate properties. The company strategically balances its stable real estate assets with high-growth potential in the life sciences sector, focusing on innovative therapies for cancer and metabolic diseases.
Additional Information
Located primarily in Newark, New Jersey, Rafael Holdings provides investors with exposure to both real estate and biotech sectors. Its dual focus allows it to leverage resources effectively, contributing to advancements in healthcare while maintaining a solid foundation in tangible property assets.
Company Information
Sector
Real Estate
Industry
Real Estate Services
Employees
28
CEO
Mr. Howard S. Jonas
Country
United States
IPO Year
2018
Website
www.rafaelholdings.comRafael Holdings Inc. (RFL) Latest News & Analysis
Latest News
Quick Summary
Rafael Holdings, Inc. (NYSE: RFL) announced revised subscription rights for its previously announced rights offering on May 5, 2025.
Why It Matters
Revised subscription rights may impact share value and investor sentiment, indicating potential changes in capital structure or dilution risks for Rafael Holdings.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Rafael Holdings, Inc. announced a $25 million rights offering for existing stockholders and warrant holders to purchase Class B common stock, aimed at funding potential launch of Trappsol® Cyclo™ pending trial results.
Why It Matters
Rafael Holdings' rights offering raises $25 million, enabling potential drug launch based on clinical trial results, impacting stock value and investor sentiment regarding future growth.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Cyclo Therapeutics' Phase 3 trial for Trappsol® Cyclo™ in Niemann-Pick Disease Type C1 is fully enrolled, with interim results expected by mid-2025.
Why It Matters
The full enrollment of Cyclo Therapeutics' trial boosts investor confidence in potential drug approval and market entry, impacting stock value and future revenue prospects.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Rafael Holdings Completes Merger with Cyclo Therapeutics Following Shareholder Approvals
1 month ago
Quick Summary
Cyclo Therapeutics' Phase 3 trial for Trappsol® Cyclo™ to treat Niemann-Pick Disease Type C1 is fully enrolled, with interim results expected mid-2025.
Why It Matters
The full enrollment of Cyclo Therapeutics' trial and upcoming interim results could significantly impact the company's stock value, reflecting investor sentiment on potential drug approval and market success.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Rafael Holdings plans to close its merger with Cyclo Therapeutics in Q3 2025, pending shareholder approvals, and will focus on Cyclo's lead clinical program Trappsol® Cyclo™ post-merger.
Why It Matters
The merger with Cyclo Therapeutics signals a strategic shift for Rafael Holdings, potentially enhancing its clinical focus and growth prospects, impacting future valuations and investor sentiment.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Kahn Swick & Foti, LLC is investigating the merger between Cyclo Therapeutics, Inc. (CYTH) and Rafael Holdings, Inc. (RFL) for fairness to shareholders.
Why It Matters
The investigation into Cyclo Therapeutics' merger with Rafael Holdings raises concerns about shareholder value and fairness, potentially impacting stock performance and investor confidence.
Source: Business Wire
Market Sentiment:
Neutral
Frequently Asked Questions About RFL Stock
What is Rafael Holdings Inc.'s (RFL) stock forecast for 2025?
Analyst forecasts for Rafael Holdings Inc. (RFL) are not currently available. The stock is trading at $1.45.
Is RFL stock a good investment in 2025?
Analyst ratings for RFL are not currently available. The stock is currently trading at $1.45. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for RFL stock?
Price predictions from Wall Street analysts for RFL are not currently available. The stock is trading at $1.45.
What is Rafael Holdings Inc.'s business model?
Rafael Holdings operates as a holding company, generating revenue through investments in biopharmaceutical companies and managing a portfolio of commercial real estate properties. The company strategically balances its stable real estate assets with high-growth potential in the life sciences sector, focusing on innovative therapies for cancer and metabolic diseases.
What is the highest forecasted price for RFL Rafael Holdings Inc.?
Price targets from Wall Street analysts for RFL are not currently available. The stock is trading at $1.45.
What is the lowest forecasted price for RFL Rafael Holdings Inc.?
Price targets from Wall Street analysts for RFL are not currently available. The stock is trading at $1.45.
What is the overall RFL consensus from analysts for Rafael Holdings Inc.?
Analyst ratings for RFL are not currently available. The stock is trading at $1.45.
How accurate are RFL stock price projections?
Stock price projections, including those for Rafael Holdings Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 12, 2025 4:55 AM UTC